Cargando…

An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report

RATIONALE: The Miller Fisher syndrome (MFS) is an acute polyradiculoneuritis regarded as an uncommon clinical variant of the Guillain-Barre syndrome (GBS). It is characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia. The diagnosis of MFS is based on clinical presentation, pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Le, Xiong, Jing, Xue, Yuying, Wang, Jie, Zhu, Xurong, Zheng, Xuejiao, Gao, Xiaoyu, Yan, YuE, Hao, Jiaduo, Zhao, Hehuan, Di, Zhengli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870176/
https://www.ncbi.nlm.nih.gov/pubmed/33592894
http://dx.doi.org/10.1097/MD.0000000000024451
_version_ 1783648763314700288
author Chang, Le
Xiong, Jing
Xue, Yuying
Wang, Jie
Zhu, Xurong
Zheng, Xuejiao
Gao, Xiaoyu
Yan, YuE
Hao, Jiaduo
Zhao, Hehuan
Di, Zhengli
author_facet Chang, Le
Xiong, Jing
Xue, Yuying
Wang, Jie
Zhu, Xurong
Zheng, Xuejiao
Gao, Xiaoyu
Yan, YuE
Hao, Jiaduo
Zhao, Hehuan
Di, Zhengli
author_sort Chang, Le
collection PubMed
description RATIONALE: The Miller Fisher syndrome (MFS) is an acute polyradiculoneuritis regarded as an uncommon clinical variant of the Guillain-Barre syndrome (GBS). It is characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia. The diagnosis of MFS is based on clinical presentation, presence of albuminocytologic dissociation in the cerebrospinal fluid (CSF), and normal brain imaging results. The presence of anti-ganglioside antibodies (GQlb) in the serum is helpful for the diagnosis. A history of upper respiratory tract infection or diarrhea 3 days to 6 weeks before the onset of MFS is common. However, there are some patients with atypical manifestations who are difficult to diagnose. Here, we present an incomplete form of MFS where antibodies against GQ1b were detected in the serum following an Epstein Barr virus (EBV) infection. PATIENT CONCERNS: A 77-year-old Chinese woman was admitted to the hospital with acute diplopia and right blepharoptosis. She had a history of mild upper respiratory tract infection 2 weeks ago. In 1 week, the symptoms rapidly progressed into bilateral ophthalmoplegia and hyporeflexia of the limbs without ataxia. CSF analysis on the third day after onset was normal, without albuminocytologic dissociation. EBV immunoglobulin G (IgG) antibodies were detected in the CSF. GQ1b and GD1b IgG antibodies were positive in the serum and negative in the CSF. No responsible lesion was found on brain imaging examination. DIAGNOSES: In accordance with the progressive bilateral ophthalmoplegia and hyporeflexia, the history of upper respiratory tract infection, the detection of EBV and GQ1b antibodies, and the negative brain imaging examination, the diagnosis of MFS was confirmed. INTERVENTIONS: The patient was administered intravenous immunoglobulin for 5 days. OUTCOMES: She had a favorable outcome after treatment. At the 6-week follow-up, bilateral ocular movement limitation and tendon reflexes had recovered. LESSONS: The diagnosis of MFS can be challenging, especially when encountered with incomplete symptoms and normal CSF results. Attention should be paid to the presence of anti-GQ1b IgG antibodies when the clinical manifestations are incomplete. Furthermore, EBV primary infection could be associated with MFS and considered a potential causative agent.
format Online
Article
Text
id pubmed-7870176
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78701762021-02-10 An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report Chang, Le Xiong, Jing Xue, Yuying Wang, Jie Zhu, Xurong Zheng, Xuejiao Gao, Xiaoyu Yan, YuE Hao, Jiaduo Zhao, Hehuan Di, Zhengli Medicine (Baltimore) 5300 RATIONALE: The Miller Fisher syndrome (MFS) is an acute polyradiculoneuritis regarded as an uncommon clinical variant of the Guillain-Barre syndrome (GBS). It is characterized by the clinical triad of ophthalmoplegia, ataxia, and areflexia. The diagnosis of MFS is based on clinical presentation, presence of albuminocytologic dissociation in the cerebrospinal fluid (CSF), and normal brain imaging results. The presence of anti-ganglioside antibodies (GQlb) in the serum is helpful for the diagnosis. A history of upper respiratory tract infection or diarrhea 3 days to 6 weeks before the onset of MFS is common. However, there are some patients with atypical manifestations who are difficult to diagnose. Here, we present an incomplete form of MFS where antibodies against GQ1b were detected in the serum following an Epstein Barr virus (EBV) infection. PATIENT CONCERNS: A 77-year-old Chinese woman was admitted to the hospital with acute diplopia and right blepharoptosis. She had a history of mild upper respiratory tract infection 2 weeks ago. In 1 week, the symptoms rapidly progressed into bilateral ophthalmoplegia and hyporeflexia of the limbs without ataxia. CSF analysis on the third day after onset was normal, without albuminocytologic dissociation. EBV immunoglobulin G (IgG) antibodies were detected in the CSF. GQ1b and GD1b IgG antibodies were positive in the serum and negative in the CSF. No responsible lesion was found on brain imaging examination. DIAGNOSES: In accordance with the progressive bilateral ophthalmoplegia and hyporeflexia, the history of upper respiratory tract infection, the detection of EBV and GQ1b antibodies, and the negative brain imaging examination, the diagnosis of MFS was confirmed. INTERVENTIONS: The patient was administered intravenous immunoglobulin for 5 days. OUTCOMES: She had a favorable outcome after treatment. At the 6-week follow-up, bilateral ocular movement limitation and tendon reflexes had recovered. LESSONS: The diagnosis of MFS can be challenging, especially when encountered with incomplete symptoms and normal CSF results. Attention should be paid to the presence of anti-GQ1b IgG antibodies when the clinical manifestations are incomplete. Furthermore, EBV primary infection could be associated with MFS and considered a potential causative agent. Lippincott Williams & Wilkins 2021-02-05 /pmc/articles/PMC7870176/ /pubmed/33592894 http://dx.doi.org/10.1097/MD.0000000000024451 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5300
Chang, Le
Xiong, Jing
Xue, Yuying
Wang, Jie
Zhu, Xurong
Zheng, Xuejiao
Gao, Xiaoyu
Yan, YuE
Hao, Jiaduo
Zhao, Hehuan
Di, Zhengli
An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report
title An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report
title_full An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report
title_fullStr An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report
title_full_unstemmed An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report
title_short An incomplete form of anti-ganglioside antibody-positive Miller Fisher syndrome after an Epstein-Barr virus infection: A case report
title_sort incomplete form of anti-ganglioside antibody-positive miller fisher syndrome after an epstein-barr virus infection: a case report
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870176/
https://www.ncbi.nlm.nih.gov/pubmed/33592894
http://dx.doi.org/10.1097/MD.0000000000024451
work_keys_str_mv AT changle anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT xiongjing anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT xueyuying anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT wangjie anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT zhuxurong anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT zhengxuejiao anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT gaoxiaoyu anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT yanyue anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT haojiaduo anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT zhaohehuan anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT dizhengli anincompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT changle incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT xiongjing incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT xueyuying incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT wangjie incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT zhuxurong incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT zhengxuejiao incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT gaoxiaoyu incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT yanyue incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT haojiaduo incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT zhaohehuan incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport
AT dizhengli incompleteformofantigangliosideantibodypositivemillerfishersyndromeafteranepsteinbarrvirusinfectionacasereport